Metabolomics in Preclinical Drug Safety Assessment: Current Status and Future Trends

Metabolomics in Preclinical Drug Safety Assessment: Current Status and Future Trends

Metabolomics is emerging as a powerful systems biology approach for improving preclinical drug safety assessment. This review discusses current applications and future trends of metabolomics in toxicology and drug development. Metabolomics can elucidate adverse outcome pathways by detecting endogeno...

Full description

Bibliographic Details
Main Authors: Fenna Sillé, Thomas Hartung
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Metabolites
Subjects:
metabolomics
toxicity
safety
drug development
adverse outcome pathways
Online Access:https://www.mdpi.com/2218-1989/14/2/98

Similar Items

Similar Items